Liver Cirrhosis — Effects on Liver Cirrhotic Patients' by a Nurse-led Clinic
Citation(s)
Abdi F, Daryani NE, Khorvash F, Yousefi Z Experiences of Individuals With Liver Cirrhosis: A Qualitative Study. Gastroenterol Nurs. 2015 Jul-Aug;38(4):252-7. doi: 10.1097/SGA.0000000000000122.
Arguedas MR, DeLawrence TG, McGuire BM Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003 Aug;48(8):1622-6. doi: 10.1023/a:1024784327783.
Brown MT, Bussell JK Medication adherence: WHO cares? Mayo Clin Proc. 2011 Apr;86(4):304-14. doi: 10.4065/mcp.2010.0575. Epub 2011 Mar 9.
Chaney A, Werner KT & Kipple T Primary care management of hepatic encephalopathy: A common cirrhosis complication. The journal for Nurse Practisioners. 11(3): 300-306, 2015.
Disler RT, Gallagher RD, Davidson PM Factors influencing self-management in chronic obstructive pulmonary disease: an integrative review. Int J Nurs Stud. 2012 Feb;49(2):230-42. doi: 10.1016/j.ijnurstu.2011.11.005. Epub 2011 Dec 6.
Evangelista LS, Shinnick MA What do we know about adherence and self-care? J Cardiovasc Nurs. 2008 May-Jun;23(3):250-7. doi: 10.1097/01.JCN.0000317428.98844.4d.
Hays RD, Morales LS The RAND-36 measure of health-related quality of life. Ann Med. 2001 Jul;33(5):350-7. doi: 10.3109/07853890109002089.
Hays RD, Sherbourne CD, Mazel RM The RAND 36-Item Health Survey 1.0. Health Econ. 1993 Oct;2(3):217-27. doi: 10.1002/hec.4730020305.
Hommel A, Idvall E & Andersson AC Kvalitetsutveckling: Kvalitet och omvårdnad. I AK Edberg, A Ehrenberg, F Friberg, L Wallin, H Wijk & J Öhlén (Eds) Omvårdnad på avancerad nivå: Kärnkompetenser inom sjuksköterskans specialistområden (1st ed, pp. 147-150), 2013.
Infante-Rivard C, Esnaola S, Villeneuve JP Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 1987 Jul-Aug;7(4):660-4. doi: 10.1002/hep.1840070408.
Jones JC, Coombes JS, Macdonald GA Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012 Feb;18(2):146-51. doi: 10.1002/lt.22472.
Jorgensen R A phenomenological study of fatigue in patients with primary biliary cirrhosis. J Adv Nurs. 2006 Sep;55(6):689-97. doi: 10.1111/j.1365-2648.2006.03958.x.
Kalaitzakis E, Josefsson A, Bjornsson E Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol. 2008 Oct 15;8:46. doi: 10.1186/1471-230X-8-46.
Kirkevold M Omvårdnadsteorier; Analys och utvärdering (2nd Ed). Lund: Studentlitteratur, 2000.
Koay K, Schofield P, Jefford M Importance of health literacy in oncology. Asia Pac J Clin Oncol. 2012 Mar;8(1):14-23. doi: 10.1111/j.1743-7563.2012.01522.x.
Kroese ME, Severens JL, Schulpen GJ, Bessems MC, Nijhuis FJ, Landewe RB Specialized rheumatology nurse substitutes for rheumatologists in the diagnostic process of fibromyalgia: a cost-consequence analysis and a randomized controlled trial. J Rheumatol. 2011 Jul;38(7):1413-22. doi: 10.3899/jrheum.100753. Epub 2011 Apr 1.
Larsson G, Larsson BW, Munck IM Refinement of the questionnaire 'quality of care from the patient's perspective' using structural equation modelling. Scand J Caring Sci. 1998;12(2):111-8.
Prytz H & Ståhl P Levercirros och dess kliniska manifestationer. I R Hultcrantz, A Bergquist, S Lindgren, M Simrén, P Stål & OB Suhr (Eds.). Gastroenterologi och hepatologi. Stockholm: Liber. (1st ed, pp. 451-475), 2011.
Riley TR, Taheri M, Schreibman IR Does weight history affect fibrosis in the setting of chronic liver disease? J Gastrointestin Liver Dis. 2009 Sep;18(3):299-302.
Schadewaldt V, Schultz T Nurse-led clinics as an effective service for cardiac patients: results from a systematic review. Int J Evid Based Healthc. 2011 Sep;9(3):199-214. doi: 10.1111/j.1744-1609.2011.00217.x.
Shen C, Zhao CY, Zhang R, Qiao L Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Front Biosci (Landmark Ed). 2012 Jun 1;17(6):2356-70. doi: 10.2741/4057.
Shutt JD, Robathan J, Vyas SK Impact of a clinical nurse specialist on the treatment of chronic hepatitis C. Br J Nurs. 2008 May 8-21;17(9):572-5. doi: 10.12968/bjon.2008.17.9.29242.
Volk ML, Fisher N, Fontana RJ Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol. 2013 Mar;108(3):302-5. doi: 10.1038/ajg.2012.214.
Wigg AJ, McCormick R, Wundke R, Woodman RJ Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol. 2013 Jul;11(7):850-8.e1-4. doi: 10.1016/j.cgh.2013.01.014. Epub 2013 Jan 29.
Wilde B, Starrin B, Larsson G, Larsson M Quality of care from a patient perspective--a grounded theory study. Scand J Caring Sci. 1993;7(2):113-20. doi: 10.1111/j.1471-6712.1993.tb00180.x.
Wilde Larsson B, Larsson G Development of a short form of the Quality from the Patient's Perspective (QPP) questionnaire. J Clin Nurs. 2002 Sep;11(5):681-7. doi: 10.1046/j.1365-2702.2002.00640.x.
Effects on Liver Cirrhotic Patient's Health Related Quality of Life by a Nurse-led Clinic: A Multicenter Randomized Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.